CD274 and neoplasm: Interaction between PD-L1 and its receptor PD-1 modifies the immune response in the tumor microenvironment, particularly by decreasing the effectiveness of physiological anti-tumor mechanisms [21] and by preventing the activation of cytotoxic T-cells [22,23].